Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9060992 Treatment of short bowel syndrome patients with colon-in-continuity

Patent 9060992 was granted and assigned to Nps Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+182 characters)
Article

Patent abstract

Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.

Edits on 28 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Consuelo Maria Blosch0
Elizabeth Lemaire Sanguinetti0
Jennifer Lopansri0
Thomas B. Marriott0
Edits on 27 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11766470 Manufacture, formulation and dosing of apraglutide
Edits on 31 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11660328 GLP-2 analogs and peptibodies for administration before, during or after surgery
0
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090609920
Edits on 23 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09060992 Treatment of short bowel syndrome patients with colon-in-continuity US Patent 9060992 Treatment of short bowel syndrome patients with colon-in-continuity

Infobox
Patent Number
090609920
Patent Number
90609920
Edits on 7 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Nps Pharmaceuticals
Nps Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
090609920
Date of Patent
June 23, 2015
0
Patent Application Number
129381170
Date Filed
November 2, 2010
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090609920
Patent Primary Examiner
‌
Satyanarayana R Gudibande
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09060992
Edits on 2 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09060992 Treatment of short bowel syndrome patients with colon-in-continuity

Infobox
Is a
Patent
Patent
Current assignee
Nps Pharmaceuticals
Nps Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09060992
Date of patent
June 23, 2015
Patent application number
12938117
Date Filed
November 2, 2010
Patent primary examiner
‌
Satyanarayana R Gudibande

Find more entities like US Patent 9060992 Treatment of short bowel syndrome patients with colon-in-continuity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo